Compare Stocks

→ A.I. “Perfect Storm” Could Send THESE Stocks Sky High (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALSSF Alsea	$4.30	$4.22	$2.35 ▼ $4.95	N/A	N/A	14,371 shs	2,000 shs
BPZZF Boston Pizza Royalties Income Fund	$11.63	$11.53	$10.50 ▼ $12.80	N/A	N/A	818 shs	61 shs
CARA Cara Therapeutics	$0.71 0.0%	$0.81	$0.50 ▼ $4.67	$38.80M	0.7	670,849 shs	51,492 shs
VGID V Group		$0.00	$0.00 ▼ $0.00	N/A	N/A	3.25 million shs	N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALSSF Alsea	0.00%	-7.53%	+0.23%	+14.67%	+69.29%
BPZZF Boston Pizza Royalties Income Fund	-1.98%	-0.70%	-2.48%	-0.26%	-3.55%
CARA Cara Therapeutics	-7.08%	-13.99%	-19.14%	+32.46%	-83.22%
VGID V Group	0.00%	0.00%	0.00%	-66.67%	-50.00%

Elon Musk’s ChatGPT Could Soon Mint New Millionaires (Ad)

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

And you could go along for the ride if you make this one simple move.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALSSF Alsea	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CARA Cara Therapeutics	3.9156 of 5 stars	3.4	2.0	0.0	4.2	1.9	1.7	1.3
VGID V Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALSSF Alsea	N/A	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A	N/A	N/A	N/A
CARA Cara Therapeutics	2.75	Moderate Buy	$9.75	1,273.43% Upside
VGID V Group	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest VGID, ALSSF, BPZZF, and CARA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/10/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
3/28/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
3/6/2024	CARA Cara Therapeutics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$11.00 ➝ $10.00
3/5/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
1/22/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$6.00 ➝ $5.00

(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALSSF Alsea	N/A	N/A	N/A	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A	N/A	N/A	N/A	N/A	N/A
CARA Cara Therapeutics	$20.97M	1.85	N/A	N/A	$1.05 per share	0.68
VGID V Group	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALSSF Alsea	N/A	$1.06	4.06	∞	N/A	N/A	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A	$1.26	9.26	∞	N/A	N/A	N/A	N/A	5/8/2024 (Estimated)
CARA Cara Therapeutics	-$118.51M	-$2.18	N/A	N/A	N/A	-565.21%	-122.10%	-89.64%	5/20/2024 (Estimated)
VGID V Group	N/A	-$0.18	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest VGID, ALSSF, BPZZF, and CARA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/4/2024	12/31/2023	CARA Cara Therapeutics	-$0.57	-$0.59	-$0.02	-$0.59	$2.34 million	$3.00 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALSSF Alsea	N/A	N/A	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	$0.82	7.02%	N/A	65.00%	N/A
CARA Cara Therapeutics	N/A	N/A	N/A	N/A	N/A
VGID V Group	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALSSF Alsea	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A	N/A	N/A
CARA Cara Therapeutics	N/A	4.54	4.43
VGID V Group	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ALSSF Alsea	22.50%
BPZZF Boston Pizza Royalties Income Fund	25.97%
CARA Cara Therapeutics	44.66%
VGID V Group	N/A

Insider Ownership

Company	Insider Ownership
ALSSF Alsea	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A
CARA Cara Therapeutics	4.20%
VGID V Group	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ALSSF Alsea	79,271	N/A	N/A	Not Optionable
BPZZF Boston Pizza Royalties Income Fund	N/A	N/A	N/A	Not Optionable
CARA Cara Therapeutics	55	54.66 million	52.36 million	Optionable
VGID V Group	N/A	N/A	N/A	Not Optionable

VGID, ALSSF, BPZZF, and CARA Headlines

Source	Headline
	IVCGF Iveco Group N.V. seekingalpha.com - April 6 at 12:46 AM
	3 Auto Stock Buys Driving Gains stocknews.com - March 28 at 12:17 PM
	Volkswagen showcases new variants of the Virtus and Taigun msn.com - March 27 at 3:49 AM
	VW puts ID GTI on radar for U.S. lineup autonews.com - March 15 at 10:56 AM
	Verve Hires Veteran Agent Valarie Phillips msn.com - March 14 at 2:31 AM
	REVG Stock Earnings: REV Group Beats EPS, Beats Revenue for Q1 2024 investorplace.com - March 6 at 2:00 PM
	Groupthink gives V-22 a bad rap defenseone.com - February 25 at 12:00 PM
	Graphene Manufacturing Group Ltd (GMG.V) ca.finance.yahoo.com - February 15 at 7:29 AM
	REV Group, Inc. Announces Pricing of Upsized Secondary Offering of Common Stock and Concurrent Share Repurchase businesswire.com - February 14 at 8:12 PM
	STLA Earnings Impact: Buy or Hold Decision? stocknews.com - February 14 at 3:03 PM
	IMO Secretary General Arsenio Domínguez meets with Chairman of V Group Vyron Vasileiadis en.protothema.gr - February 11 at 8:05 AM
	The Hempshire Group, Inc. (HMPG.V) ca.finance.yahoo.com - February 10 at 9:46 AM
	V-LINE, Verusen Partner to Assist with Saudi Supply Chain Optimization supplychainbrain.com - January 27 at 3:44 AM
	PMVG, Distributed Media Lab Partner On News Syndication Network Offering msn.com - January 25 at 6:21 PM
	Is Lucid Group (LCID) a Hidden Gem or a Risky Bet in the Auto Industry? stocknews.com - January 5 at 10:02 PM
	Rhodes Unveils V-Pan Plugin: Elevate Your Sonic Landscape with Iconic Vari-Pan Effects – Free Until End of January 2024 twice.com - December 21 at 12:11 AM
	Prince Harry v Mirror Group: key findings of phone-hacking case theguardian.com - December 17 at 8:38 PM
	Shift Into High Gear with These 3 Auto Stocks Primed for December Rally stocknews.com - December 15 at 11:10 AM
	REVG Stock Earnings: REV Group Beats EPS, Beats Revenue for Q4 2023 investorplace.com - December 13 at 2:02 PM
	Azerion Group N.v. Share Price (AZRNW.AM) lse.co.uk - December 8 at 11:52 PM
	Analysts Offer Insights on NA Companies: Vitesco Technologies Group AG (OtherVTSCF) and DraftKings (DKNG) markets.businessinsider.com - November 15 at 3:22 AM
	Morefield Group N.v. Share Price (MORE.AM) lse.co.uk - November 12 at 10:25 AM
	‘Gen V’ Hints That Marie May Be More Powerful Than Homelander msn.com - October 21 at 2:03 PM
	V.F. Corp.: A Real Value Trap - Avoid Catching This Falling Knife (Rating Downgrade) msn.com - October 15 at 2:44 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Alsea

OTCMKTS:ALSSF

Alsea, S.A.B. de C.V. operates restaurants in Latin America and Europe. It operates fast food, coffee shops, casual food, and family restaurants under the Domino's Pizza, Starbucks, Burger King, Chili's, PF Chang's, Italianni's, The Cheesecake Factory, Vips, The gate, Foster's Hollywood, Archies, Ginos, T.G.I. Fridays, Vips Europe, Vips Smart, Ole Mole, and Clay Hear brands. The company was incorporated in 1997 and is headquartered in Mexico City, Mexico.

Boston Pizza Royalties Income Fund

OTCMKTS:BPZZF

Boston Pizza Royalties Income Fund operates as a limited purpose open-ended trust. The company, indirectly through Boston Pizza Royalties Limited Partnership, owns trade-marks used by Boston Pizza International Inc. It operates and franchises Boston Pizza restaurants. The company was founded in 1964 and is based in Richmond, Canada. Boston Pizza Royalties Income Fund operates as a subsidiary of James Treliving Holdings Ltd.

Cara Therapeutics

NASDAQ:CARA

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

V Group

OTCMKTS:VGID

V Group, Inc. provides beverages primarily in the United States. It offers antioxidant nutritional drinks in natural flavors, such as Love Red, Powerful Purple, Outrageous Orange, and Raw Green under the and brand. The company is based in Carlsbad, California.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial